1. Home
  2. CURI vs CRBU Comparison

CURI vs CRBU Comparison

Compare CURI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CuriosityStream Inc.

CURI

CuriosityStream Inc.

HOLD

Current Price

$3.34

Market Cap

193.6M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.88

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURI
CRBU
Founded
N/A
2011
Country
United States
United States
Employees
45
N/A
Industry
Movies/Entertainment
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.6M
203.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CURI
CRBU
Price
$3.34
$1.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$5.83
$10.75
AVG Volume (30 Days)
376.4K
1.2M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
10.00%
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.52
N/A
Revenue Next Year
$16.90
$10.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$0.66
52 Week High
$7.15
$3.53

Technical Indicators

Market Signals
Indicator
CURI
CRBU
Relative Strength Index (RSI) 46.16 53.25
Support Level $3.07 $1.70
Resistance Level $4.96 $2.11
Average True Range (ATR) 0.19 0.14
MACD 0.01 -0.00
Stochastic Oscillator 40.96 37.72

Price Performance

Historical Comparison
CURI
CRBU

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: